HIV-1 dynamics in children

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 20, Issue 5, 1999, Pages 468-473

  Melvin, Ann J ^a,d   Rodrigo, Allen G ^b   Mohan, Kathleen M ^a   Lewis, Paul A ^c   Manns Arcuino, Laura ^a   Coombs, Robert W ^b   Mullins, James I ^b   Frenkel, Lisa M ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d NONE   (United States)

Author keywords

Pediatrics; Viral dynamics

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; VIRUS RNA;

ADOLESCENT; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; LEUKOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS INFECTION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0033561273     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199904150-00009     Document Type: Article

References (18)

1. Barnhart HX, Caldwell MB, Thomas P, et al. Natural history of human immunodeficiency virus disease in perinatally infected children: an analysis from the Pediatric Spectrum of Disease Project. Pediatrics 1996;97:710-6.
2. Hessol NA, Koblin BA, van Griensven GJ, et al. Progression of human immunodeficiency virus type 1 (HIV-1) infection among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1991. Am J Epidemiol 1994;139:1077-87.
3. Mellors JW, Rinaldo CR, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272:1167-70.
4. Shearer WT, Quinn TC, LaRussa P, et al. Viral load and disease progression in infants infected with human immunodeficiency virus type 1. N Engl J Med 1997;336:1337-42.
5. + lymphocyte count in HIV-infected infants and children. JAMA 1998;279:756-61.
6. Paediatric European Network for Treatment of AIDS (PENTA). HIV-1 viral load and CD4 cell count in untreated children with vertically acquired asymptomatic or mild disease. AIDS 1998;12: Fl-8.
7. Mulder J, Resnick R, Saget B, et al. A rapid and simple method for extracting human immunodeficiency virus type 1 RNA from plasma: enhanced sensitivity. J Clin Microbiol 1997;35:1278-80.
8. Boom R, Sol CJA, Salimans MMM, Jansen CL, Wertheim-van Dillen PME, van der Noordaa J. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990;28:495-503.
9. Perelson AS, Essunger P, Cao Y, et al. Decay characteristics of HIV-1 -infected compartments during combination therapy. Nature 1997;387:188-91.
10. Ratkowski DA. Handbook of Nonlinear Regression Models. New York: Marcel Dekker Inc., 1990.
11. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD. HIV-1 dynamics in vivo: virion clearance rate, infected cell lifespan, and viral generation time. Science 1996;271:1582-6.
12. Heath SL, Tew JG, Tew JG, Szakal AK, Burton GF. Follicular dendritic cells and human immunodeficiency virus infectivity. Nature 1995;377:740-4.
13. Chun T-W, Stuyver L, Mizell SB, et al. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci USA 1997;94:13193-7.
14. Martel L, Valentine M, Ferguson L, Muelenaer P, Katz SL, McKinney RE. Virologic and CD4 response to treatment with nelfinavir in therapy experienced but protease inhibitor naive HIV-infected children [Abstract 233]. 5th Conference on Retrovirus and Opportunistic Infections, Chicago, Illinois, U.S.A., 1998.
15. Melvin AJ, Mohan KM, Manns-Arcuino LA, Edelstein RE, Frenkel LM. Clinical, virologie, and immunologic responses of children with advanced HIV-1 disease treated with protease inhibitors. Pediatr Infect Dis 1997;16:968-74.
16. Luzuriaga K, Bryson Y, Krogstad P, et al. Combination treatment with zidovudine, didanosine, and nevirapine in infants with human immunodeficiency virus type 1 infection. N Engl J Med 1997;336: 1343-9.
17. Rhone S, Hogg R, Yip B, et al. Antiviral effect of double and triple drug combinations among HIV infected adults: lessons from viral load driven antiretroviral therapy [Abstract 1-103]. Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Ontario, Canada, 1997.
18. Demeter L, Hughes M, Fischl M, et al. Predictors of virologie and clinical responses to indinavir [Abstract 509]. 5th Conference on Retroviruses and Opportunistic Infections, Chicago, Illinois, U.S.A., 1998.